Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

FDA News Topic Center

Featured Article

News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Jolynn Tumolo
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Asthma Med Recalled
04/14/2023
Jolynn Tumolo
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
Jolynn Tumolo
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
FDA Approves Factor VIII Replacement Therapy for Hemophilia A
03/09/2023
Maria Asimopoulos
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor...
03/09/2023
First Report Managed Care
From First Report Managed Care
News
Class I Recall for Thyroid Medication
03/02/2023
Jolynn Tumolo
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Blood Thinner Recalled
03/02/2023
Jolynn Tumolo
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of...
03/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Sanitizing Products Recalled
02/10/2023
Jolynn Tumolo
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and...
02/10/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Contaminated OTC Burn Cream Prompts Class I Recall
02/10/2023
Jolynn Tumolo
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued...
02/10/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Beta-Blocker Recalled
02/02/2023
Jolynn Tumolo
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is...
02/02/2023
Pharmacy Learning Network
From Pharmacy Learning Network

Newsfeed

News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Jolynn Tumolo
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
News
Asthma Med Recalled
04/14/2023
Jolynn Tumolo
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
Jolynn Tumolo
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network
News
FDA Approves Factor VIII Replacement Therapy for Hemophilia A
03/09/2023
Maria Asimopoulos
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor...
03/09/2023
First Report Managed Care
News
Class I Recall for Thyroid Medication
03/02/2023
Jolynn Tumolo
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
Blood Thinner Recalled
03/02/2023
Jolynn Tumolo
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of...
03/02/2023
Pharmacy Learning Network
News
Sanitizing Products Recalled
02/10/2023
Jolynn Tumolo
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and...
02/10/2023
Pharmacy Learning Network
News
Contaminated OTC Burn Cream Prompts Class I Recall
02/10/2023
Jolynn Tumolo
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued...
02/10/2023
Pharmacy Learning Network
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
Dean Celia
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
Paul Nicolaus
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024

Danielle Sposato

Danielle Sposato
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
Paul Nicolaus
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Jolynn Tumolo
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
Julie Gould
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Recent Stories

News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network
News
Two Firms Recall Statins
04/14/2023
Jolynn Tumolo
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
News
Asthma Med Recalled
04/14/2023
Jolynn Tumolo
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
News
Anxiety Drug Recalled
04/14/2023
Jolynn Tumolo
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement